4.8 Article

Rescue of oxytocin response and social behaviour in a mouse model of autism

Journal

NATURE
Volume 584, Issue 7820, Pages 252-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41586-020-2563-7

Keywords

-

Funding

  1. Long-term Fellowship from the Human Frontiers Science Program
  2. Swiss National Science Foundation
  3. European Research Council
  4. EU-AIMS
  5. Innovative Medicines Initiatives from the European Commission
  6. Innovative Medicines Initiative 2 Joint Undertaking [777394]
  7. European Union
  8. EFPIA
  9. AUTISM SPEAKS
  10. Autistica
  11. SFARI
  12. NCCR SYNAPSY
  13. Biomedical Sciences Institutes (BMSI)
  14. Joint Council Office (JCO), Agency for Science, Technology and Research (A*STAR), Singapore [11 03 FG 07 05]

Ask authors/readers for more resources

A fundamental challenge in developing treatments for autism spectrum disorders is the heterogeneity of the condition. More than one hundred genetic mutations confer high risk for autism, with each individual mutation accounting for only a small fraction of cases(1-3). Subsets of risk genes can be grouped into functionally related pathways, most prominently those involving synaptic proteins, translational regulation, and chromatin modifications. To attempt to minimize this genetic complexity, recent therapeutic strategies have focused on the neuropeptides oxytocin and vasopressin(4-6), which regulate aspects of social behaviour in mammals(7). However, it is unclear whether genetic risk factors predispose individuals to autism as a result of modifications to oxytocinergic signalling. Here we report that an autism-associated mutation in the synaptic adhesion moleculeNlgn3results in impaired oxytocin signalling in dopaminergic neurons and in altered behavioural responses to social novelty tests in mice. Notably, loss ofNlgn3is accompanied by a disruption of translation homeostasis in the ventral tegmental area. Treatment ofNlgn3-knockout mice with a new, highly specific, brain-penetrant inhibitor of MAP kinase-interacting kinases resets the translation of mRNA and restores oxytocin signalling and social novelty responses. Thus, this work identifies a convergence between the genetic autism risk factorNlgn3, regulation of translation, and oxytocinergic signalling. Focusing on such common core plasticity elements might provide a pragmatic approach to overcoming the heterogeneity of autism. Ultimately, this would enable mechanism-based stratification of patient populations to increase the success of therapeutic interventions. An autism-associated mutation inNlgn3results in impaired oxytocin signalling in dopaminergic neurons and altered social behavioural responses in mice, and treatment with an inhibitor of MAP kinase-interacting kinases rescues these phenotypes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available